VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer
Videos  >  

The Best Therapy Option for a Patient With mCRPC

Raoul Concepcion, MD
Published Online:6:24 PM, Mon November 28, 2016

Raoul Concepcion, MD, director, Comprehensive Prostate Center, discussed the best treatment option for a patient with metasatic castration-resistant prostate cancer (mCRPC) during the LUGPA Annual Meeting.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.